Journal
SMALL METHODS
Volume 2, Issue 5, Pages -Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/smtd.201700347
Keywords
autoimmune diseases; cancer immunotherapy; drug-delivery systems; nanoparticles; vaccines
Funding
- University of Helsinki Research Funds
- Sigrid Juselius Foundation [4704580]
- Helsinki Institute of Life Science
- European Research Council under the European Union's Seventh Framework Programme [310892]
Ask authors/readers for more resources
Immunotherapy is revolutionizing current therapies in cancer and in autoimmune diseases, showing impressive results in clinical trials. Recently, the development of innovative nano-biomaterials has been focusing on the interactions between such materials and the immune system, both in the adaptive and innate branches. Biomaterials can display immunostimulative, neutral, or immunosuppressive interactions. Nanoparticles displaying immunostimulative potential are employed in the formulation of cancer vaccines, while immunosuppressive materials are being researched for the development of vaccines able to induce tolerance in autoimmune diseases. Here, the properties influencing the immunomodulation effect of nanomaterials are analyzed, followed by a detailed review of the recent applications of nanomaterials for the delivery of antigens, adjuvants, chemotherapeutics, and immunomodulatory drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available